Literature DB >> 3791281

A new staging method versus TNM staging in children with posterior fossa primitive neuroectodermal tumor (medulloblastoma).

J P Laurent, W R Cheek.   

Abstract

Prognostic factors were evaluated in 30 children with primitive neuroectodermal tumors of the posterior fossa (classical medulloblastoma or differentiated medulloblastoma). The preoperative TNM (Tumor, Node, Metastasis) staging system has been applied to estimate prognosis of patients with central nervous system tumors, but this system was not applicable in assessing the postoperative status of the tumor. To fill this need, a postoperative staging system was developed known as MAPS (Metastasis, Age, Pathology, Surgery), and in this report its efficacy is compared with that of the TNM system. The predictive values of MAPS staging in these 30 children were better than those obtained using the TNM method (MAPS r2 = -0.90; TNM r2 = 0.73; P less than 0.05).

Entities:  

Mesh:

Year:  1986        PMID: 3791281     DOI: 10.1007/bf00272493

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  24 in total

1.  Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival.

Authors:  E M Chatty; K M Earle
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

2.  The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases.

Authors:  H J Bloom; E N Wallace; J M Henk
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-01

3.  Prognosis and long-term follow-up in patients with medulloblastoma.

Authors:  M Choux; G Lena; J Hassoun
Journal:  Clin Neurosurg       Date:  1983

4.  Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis.

Authors:  J C Allen; F Epstein
Journal:  J Neurosurg       Date:  1982-10       Impact factor: 5.115

5.  Radiation treatment for medulloblastoma. A 21-year review.

Authors:  M P Berry; R D Jenkin; C W Keen; B D Nair; W J Simpson
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

6.  Medulloblastoma: prognosis and prospects.

Authors:  H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Sep-Oct       Impact factor: 7.038

7.  Cerebellar medulloblastoma in adults.

Authors:  P G Hughes
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

8.  Medulloblastoma in children. Survival and treatment.

Authors:  J Mealey; P V Hall
Journal:  J Neurosurg       Date:  1977-01       Impact factor: 5.115

9.  Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure.

Authors:  C L Silverman; J R Simpson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

10.  Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management.

Authors:  G Kopelson; R M Linggood; G M Kleinman
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

View more
  1 in total

1.  Brain tumours in children. A plea for an interdisciplinary working group.

Authors:  F J Schulte; H D Herrmann
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.